19/02 2026 Redsense releases Aktiespararna CEO interview following Q4 2025 report Halmstad, Sweden, February 19, 2026 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) announces that a video interview with CEO Sebastien Bollue has been… [read more]
19/02 2026 Interim Report Q4 – October – December, 2025 Redsense Medical AB (publ.) October – December 2025 · Net sales amounted to kSEK 6,035 (12,687). · Operating loss, EBIT amounted to kSEK -1,952 (5,525). · Excl. Exchange rate… [read more]
19/11 2025 Redsense releases BioStock CEO interview following Q3 2025 report Halmstad, Sweden, November 19, 2025 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) announces that a video interview with CEO Sebastien Bollue has been… [read more]